American Academy of Pain Medicine

Many commonly held assumptions about codeine and other opioid use need to be modified, according to a consensus statement issued by the American Academy of Pain Medicine and the American Pain Society. 

American Academy of Pain Medicine and the American Pain Society also advocate the prudent use of narcotic analgesics for the treatment of chronic pain (15,16). The widespread use of opioids in chronic, nonmalignant pain, however, is still somewhat controversial because of the lack of substantial evidence from long-term controlled studies demonstrating effectiveness in this setting (17). The clinical use of opioids in different types of pain and in different clinical settings has been reviewed in detail in a recent book (18). 

S. Savage, E. C. Covington, H. A. Heit, J. Hunt, D. Joranson, and S. H. Schnoll, Definitions Related to the Use of Opioids for the Treatment of Pain, American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine, Glenview, IL, 2001. 

Candiotti KA, Yang Z, Curia L, et al. The impact of CYP2D6 genetic polymorphism on postoperative morphine consumption. Presented at the 24th Annual Meeting of the American Academy of Pain Medicine. Orlando (FL) (February 12-16, 2008). [Poster 120]. 

The use of opioids for the treatment of chronic pain A consensus statement from the American Academy of Pain Medicine and American Pain Society. Approved 1996, American Pain Society Web site www.ampainsoc.org modified September 2003 accessed March 6, 2004. 

P< 0.01 vs. placebo, V< 0.01 vs. one tablet. With permission from- DesJardins P, Diamond E, Clark F. Treatment of acute pain with 12-hour controlled-release hydrocodone-acetaminophen tablets following bunionectomy a randomized, double-blind, placebo-controlled study. The American Academy of Pain Medicine Annual Meeting, 23rd Annual Meeting, February 7-10,2007, New Orleans, LA. 

The American Academy of Pain Medicine Annual Meeting, 23rd Annual Meeting, February 7-10,2007, New Orleans, LA. 

Hitt E. Efficacy and safety evaluation of 12 weeks extended-release hydrocodone/acetaminophen treatment in patients with chronic low back pain by prior opioid use. American Academy of Pain Medicine, 2008. 

---